Literature DB >> 29326425

Unified understanding of MS course is required for drug development.

Timothy Coetzee1, Alan J Thompson2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29326425     DOI： 10.1038/nrneurol.2017.184

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Defining the clinical course of multiple sclerosis: the 2013 revisions.

Authors:  Fred D Lublin; Stephen C Reingold; Jeffrey A Cohen; Gary R Cutter; Per Soelberg Sørensen; Alan J Thompson; Jerry S Wolinsky; Laura J Balcer; Brenda Banwell; Frederik Barkhof; Bruce Bebo; Peter A Calabresi; Michel Clanet; Giancarlo Comi; Robert J Fox; Mark S Freedman; Andrew D Goodman; Matilde Inglese; Ludwig Kappos; Bernd C Kieseier; John A Lincoln; Catherine Lubetzki; Aaron E Miller; Xavier Montalban; Paul W O'Connor; John Petkau; Carlo Pozzilli; Richard A Rudick; Maria Pia Sormani; Olaf Stüve; Emmanuelle Waubant; Chris H Polman
Journal:  Neurology       Date:  2014-05-28       Impact factor: 9.910
  1 in total
  6 in total

Review 1.  The 2013 clinical course descriptors for multiple sclerosis: A clarification.

Authors:  Fred D Lublin; Timothy Coetzee; Jeffrey A Cohen; Ruth A Marrie; Alan J Thompson
Journal:  Neurology       Date:  2020-05-29       Impact factor: 9.910

2.  Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis.

Authors:  Arman Eshaghi; Rogier A Kievit; Ferran Prados; Carole H Sudre; Jennifer Nicholas; M Jorge Cardoso; Dennis Chan; Richard Nicholas; Sebastien Ourselin; John Greenwood; Alan J Thompson; Daniel C Alexander; Frederik Barkhof; Jeremy Chataway; Olga Ciccarelli
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-09       Impact factor: 11.205

3.  Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease.

Authors:  Carles Vilariño-Güell; Alexander Zimprich; Filippo Martinelli-Boneschi; Bruno Herculano; Zhe Wang; Fuencisla Matesanz; Elena Urcelay; Koen Vandenbroeck; Laura Leyva; Denis Gris; Charbel Massaad; Jacqueline A Quandt; Anthony L Traboulsee; Mary Encarnacion; Cecily Q Bernales; Jordan Follett; Irene M Yee; Maria G Criscuoli; Angela Deutschländer; Eva M Reinthaler; Tobias Zrzavy; Elisabetta Mascia; Andrea Zauli; Federica Esposito; Antonio Alcina; Guillermo Izquierdo; Laura Espino-Paisán; Jorge Mena; Alfredo Antigüedad; Patricia Urbaneja-Romero; Jesús Ortega-Pinazo; Weihong Song; A Dessa Sadovnick
Journal:  PLoS Genet       Date:  2019-06-06       Impact factor: 5.917

4.  Classification of multiple sclerosis based on patterns of CNS regional atrophy covariance.

Authors:  Charidimos Tsagkas; Katrin Parmar; Simon Pezold; Christian Barro; Mallar M Chakravarty; Laura Gaetano; Yvonne Naegelin; Michael Amann; Athina Papadopoulou; Jens Wuerfel; Ludwig Kappos; Jens Kuhle; Till Sprenger; Cristina Granziera; Stefano Magon
Journal:  Hum Brain Mapp       Date:  2021-02-24       Impact factor: 5.038

Review 5.  Charting a global research strategy for progressive MS-An international progressive MS Alliance proposal.

Authors:  Alan J Thompson; William Carroll; Olga Ciccarelli; Giancarlo Comi; Anne Cross; Alexis Donnelly; Anthony Feinstein; Robert J Fox; Anne Helme; Reinhard Hohlfeld; Robert Hyde; Pamela Kanellis; Douglas Landsman; Catherine Lubetzki; Ruth Ann Marrie; Julia Morahan; Xavier Montalban; Bruno Musch; Sarah Rawlings; Marco Salvetti; Finn Sellebjerg; Caroline Sincock; Kathryn E Smith; Jon Strum; Paola Zaratin; Timothy Coetzee
Journal:  Mult Scler       Date:  2021-12-01       Impact factor: 6.312

Review 6.  Central nervous system regeneration: the roles of glial cells in the potential molecular mechanism underlying remyelination.

Authors:  Lili Quan; Akiko Uyeda; Rieko Muramatsu
Journal:  Inflamm Regen       Date:  2022-03-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.